In addition to a better understanding of the mechanisms by which CD44 mediates cigarette smoke-suppressed MSC cell motility, this investigation identified CD44/CTTN and CD44/BIRC5 signaling pathways as potential targets to pave the way towards the design of therapeutic strategies against cancer, emphysema and other CD44-associated diseases 40. This evidence concerns the gene CTTN and pulmonary emphysema.